前列腺癌间歇性内分泌治疗进展  

Progression of intermittent androgen deprivation for prostate cancer

作　　者：罗文强 张心如[1] LUO Wenqiang ZHANG Xinru(Department of Urology, Sixth People＇s Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, 200233, Chin)

机构地区：[1]上海交通大学附属第六人民医院泌尿外科,上海200233

出　　处：《临床泌尿外科杂志》2017年第9期726-729,共4页Journal of Clinical Urology

摘　　要：近年来前列腺癌在中国的发病率逐年上升,尤其对于超过60岁的男性。世界范围内,前列腺癌发病率在男性所有恶性肿瘤中位居第二。临床上前列腺癌主要治疗方法为根治性手术或放射治疗。而对于转移性前列腺癌或无法行根治性前列腺切除术和根治放射治疗的患者,内分泌治疗为首选治疗。而且近年来前列腺癌间歇性内分泌治疗的重要性及认可度逐渐提高,本文将对前列腺癌间歇性内分泌治疗最新的研究进展作一总结,以期为前列腺癌内分泌治疗提供新的思路。In recent years,the morbidity of prostate cancer in China has increased year by year,especially for old men above 60 years old.Worldwide,it reached the second place of all malignant tumors in men.Clinically,the main treatment for prostate cancer is radical surgery or radiotherapy.Androgen deprivation therapy is the first choice for patients with metastatic prostate cancer or who are unable to undergo radical prostatectomy or radical radiotherapy.And in recent years the importance of intermittent androgen deprivation has been recognised by most surgeons.In order to provide some new ideas for the treatment of prostate cancer,we collected and summarized the latest research results.

关 键 词：前列腺癌 间歇性 内分泌治疗 

分 类 号：R737.25[医药卫生—肿瘤]